Wellteq Integrates With Garmin and UFIT for Hybrid Corporate Health & Wellness Solution Biotech Investing
Aptose to Report First Quarter 2021 Financial Results and Hold Conference Call on Tuesday, May 4, 2021 Â Biotech Investing
PLUG, WKHS & BLU Upcoming Deadlines: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders of Class Actions and Encourages Investors to Contact the Firm Biotech Investing
LEAD PLAINTIFF DEADLINE: Johnson Fistel, LLP Encourages Investors to Contact the Firm Biotech Investing
ROSEN, A RESPECTED LAW FIRM, Encourages BELLUS Health Inc. Investors With Losses to Secure Counsel Before Important May 17 Deadline in Securities Class Action - BLU Biotech Investing
OTEZLA® Significantly Improved Measures Of Disease Severity In Adults With Mild-To-Moderate Plaque Psoriasis Biotech Investing
Bristol Myers Squibb Presents Positive Data from Two Pivotal Phase 3 Psoriasis Studies Demonstrating Superiority of Deucravacitinib Compared to Placebo and Otezla® Biotech Investing
Naturally Splendid Receives Additional Container of NATERA Plant Based Foods from Australia Biotech Investing
AbbVie Receives Positive CHMP Opinion for VENCLYXTO® as a Combination Regimen for Adult Patients with Newly Diagnosed Acute Myeloid Leukemia Who Are Ineligible for Intensive Chemotherapy Biotech Investing
